The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

According to the Centers for Disease Control (CDC), Approximately 11% of Children ages 14-17 were diagnosed with Attention Deficit Hyperactive Disorder (ADHD) in 2011.   Because parents want their child to be able to focus and do well in school, children are often prescribed a medication to help keep their ADHD under control.  One such medication is Risperdal.

Risperdal was originally approved by the Food and Drug Administration (FDA) in 1993 as an antipsychotic. It was approved for the use in children in 2006 and was marketed as a safe and effective treatment for ADHD.

However, Risperdal was not as safe as the manufacturers, Johnson and Johnson, led doctors and patients to believe.

Young men who took Risperdal during Adolescence were more at risk for developing gynecomastia, or the appearance of male breasts.  Johnson and Johnson knew that Risperdal could increase the production of the hormone prolactin and cause boys to develop breasts.  However parents were not aware of the potential side effects that Risperdal was could cause their children, nor were their doctors.

It wasn’t until these young men starting going through puberty that they noticed a link between Risperdal and breast growth.  Because Johnson and Johnson kept the link been Risperdal and Gynecomastia concealed, many of these victims have filed Risperdal Lawsuits to seek justice against Johnson and Johnson as well as compensation for the surgery that was needed to reverse the effects of Risperdal.

Comments are closed.

Of Interest